Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery

Gynecologic Oncology

Volumn 138, Issue 3, 2015, Pages 560-565

  Ataseven, Beyhan ^a   Du Bois, Andreas ^a   Reinthaller, Alexander ^b   Traut, Alexander ^a   Heitz, Florian ^a   Aust, Stefanie ^b   Prader, Sonia ^a   Polterauer, Stephan ^b   Harter, Philipp ^a   Grimm, Christoph ^a,b  

^a KLINIKEN ESSEN MITTE   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Complication rate; Epithelial ovarian cancer; Low serum albumin; Mortality; Overall survival

Indexed keywords

SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CYTOREDUCTIVE SURGERY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOALBUMINEMIA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MULTIPLE ORGAN FAILURE; OPERATION DURATION; OPERATIVE BLOOD LOSS; OVARY CARCINOMA; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; TOXIC SHOCK SYNDROME; BLOOD; METABOLISM; MIDDLE AGED; MORTALITY; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PREOPERATIVE PERIOD; PROGNOSIS; RISK FACTOR; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPOALBUMINEMIA; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84941334194     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.07.005     Document Type: Article

References (39)

1. G.D. Aletti, S.C. Dowdy, B.S. Gostout, M.B. Jones, C.R. Stanhope, T.O. Wilson, and et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer Obstet. Gynecol. 107 2006 77 85
2. R.E. Bristow, R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 20 2002 1248 1259
3. A. du Bois, A. Reuss, E. Pujade-Lauraine, P. Harter, I. Ray-Coquard, and J. Pfisterer Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO) Cancer 115 2009 1234 1244
4. S.M. Eisenkop, R.L. Friedman, and H.J. Wang Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study Gynecol. Oncol. 69 1998 103 108
5. G.D. Aletti, E.L. Eisenhauer, A. Santillan, A. Axtell, G. Aletti, C. Holschneider, and et al. Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment Gynecol. Oncol. 120 2011 23 28
6. G.D. Aletti, S.C. Dowdy, K.C. Podratz, and W.A. Cliby Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer Am. J. Obstet. Gynecol. 197 2007 (676 e1-7)
7. J.P. Geisler, G.C. Linnemeier, A.J. Thomas, and K.J. Manahan Nutritional assessment using prealbumin as an objective criterion to determine whom should not undergo primary radical cytoreductive surgery for ovarian cancer Gynecol. Oncol. 106 2007 128 131
8. A. Obermair, S. Hagenauer, D. Tamandl, R.D. Clayton, J.L. Nicklin, L.C. Perrin, and et al. Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer Gynecol. Oncol. 83 2001 115 120
9. S. Uppal, A. Al-Niaimi, L.W. Rice, S.L. Rose, D.M. Kushner, R.J. Spencer, and et al. Preoperative hypoalbuminemia is an independent predictor of poor perioperative outcomes in women undergoing open surgery for gynecologic malignancies Gynecol. Oncol. 131 2013 416 422
10. G. Fanali, A. di Masi, V. Trezza, M. Marino, M. Fasano, and P. Ascenzi Human serum albumin: from bench to bedside Mol. Asp. Med. 33 2012 209 290
11. C.M. Mendez, C.J. McClain, and L.S. Marsano Albumin therapy in clinical practice Nutr. Clin. Pract. 20 2005 314 320
12. V. Asher, J. Lee, and A. Bali Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer Med. Oncol. 29 2012 2005 2009
13. K.A. Kudsk, E.A. Tolley, R.C. DeWitt, P.G. Janu, A.P. Blackwell, S. Yeary, and et al. Preoperative albumin and surgical site identify surgical risk for major postoperative complications JPEN J. Parenter. Enteral Nutr. 27 2003 1 9
14. K.G. Lee, H.J. Lee, J.Y. Yang, S.Y. Oh, S. Bard, Y.S. Suh, and et al. Risk factors associated with complication following gastrectomy for gastric cancer: retrospective analysis of prospectively collected data based on the Clavien-Dindo system J. Gastrointest. Surg. 18 2014 1269 1277
15. V. Seebacher, C. Grimm, A. Reinthaller, G. Heinze, C. Tempfer, L. Hefler, and et al. The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer Eur. J. Obstet. Gynecol. Reprod. Biol. 171 2013 101 106
16. A. Weimann, M. Braga, L. Harsanyi, A. Laviano, O. Ljungqvist, P. Soeters, and et al. ESPEN guidelines on enteral nutrition: surgery including organ transplantation Clin. Nutr. 25 2006 224 244
17. B. Laky, M. Janda, G. Cleghorn, and A. Obermair Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients Am. J. Clin. Nutr. 87 2008 1678 1685
18. B. Laky, M. Janda, J. Bauer, C. Vavra, G. Cleghorn, and A. Obermair Malnutrition among gynaecological cancer patients Eur. J. Clin. Nutr. 61 2007 642 646
19. A. du Bois, M. Quinn, T. Thigpen, J. Vermorken, E. Avall-Lundqvist, M. Bookman, and et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) Ann. Oncol. 16 Suppl. 8 2005 viii7 viii12
20. G.C. Stuart, H. Kitchener, M. Bacon, A. duBois, M. Friedlander, J. Ledermann, and et al. 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference Int. J. Gynecol. Cancer 21 2011 750 755
21. G.D. Aletti, A. Santillan, E.L. Eisenhauer, J. Hu, G. Aletti, K.C. Podratz, and et al. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model Gynecol. Oncol. 107 2007 99 106
22. B.T. Doumas, W.A. Watson, and H.G. Biggs Albumin standards and the measurement of serum albumin with bromcresol green Clin. Chim. Acta 31 1971 87 96
23. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann. Surg. 240 2004 205 213
24. D.S. Chi, O. Zivanovic, K.L. Levinson, V. Kolev, J. Huh, J. Dottino, and et al. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas Gynecol. Oncol. 119 2010 38 42
25. S.F. Khuri, J. Daley, W. Henderson, K. Hur, J.O. Gibbs, G. Barbour, and et al. Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study J. Am. Coll. Surg. 185 1997 315 327
26. T. Watanabe, M. Shibata, H. Nishiyama, S. Soeda, S. Furukawa, K. Gonda, and et al. Serum levels of rapid turnover proteins are decreased and related to systemic inflammation in patients with ovarian cancer Oncol. lett. 7 2014 373 377
27. T. Yazawa, M. Shibata, K. Gonda, T. Machida, S. Suzuki, A. Kenjo, and et al. Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers Mol. Clin. Oncol. 1 2013 675 679
28. M. Braga, O. Ljungqvist, P. Soeters, K. Fearon, A. Weimann, and F. Bozzetti ESPEN guidelines on parenteral nutrition: surgery Clin. Nutr. 28 2009 378 386
29. J. Xu, Y. Zhong, D. Jing, and Z. Wu Preoperative enteral immunonutrition improves postoperative outcome in patients with gastrointestinal cancer World J. Surg. 30 2006 1284 1289
30. B. Jie, Z.M. Jiang, M.T. Nolan, S.N. Zhu, K. Yu, and J. Kondrup Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk Nutrition 28 2012 1022 1027
31. B. Jie, Z.M. Jiang, M.T. Nolan, D.T. Efron, S.N. Zhu, K. Yu, and et al. Impact of nutritional support on clinical outcome in patients at nutritional risk: a multicenter, prospective cohort study in Baltimore and Beijing teaching hospitals Nutrition 26 2010 1088 1093
32. M. Braga, L. Gianotti, L. Nespoli, G. Radaelli, and V. Di Carlo Nutritional approach in malnourished surgical patients: a prospective randomized study Arch. Surg. 137 2002 174 180
33. F. Bozzetti, M. Braga, L. Gianotti, C. Gavazzi, and L. Mariani Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial Lancet 358 2001 1487 1492
34. F. Bozzetti, C. Gavazzi, R. Miceli, N. Rossi, L. Mariani, L. Cozzaglio, and et al. Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial JPEN J. Parenter. Enteral Nutr. 24 2000 7 14
35. M. Hubner, Y. Cerantola, F. Grass, P.C. Bertrand, M. Schafer, and N. Demartines Preoperative immunonutrition in patients at nutritional risk: results of a double-blinded randomized clinical trial Eur. J. Clin. Nutr. 66 2012 850 855
36. K. Fujitani, T. Tsujinaka, J. Fujita, I. Miyashiro, H. Imamura, Y. Kimura, and et al. Prospective randomized trial of preoperative enteral immunonutrition followed by elective total gastrectomy for gastric cancer Br. J. Surg. 99 2012 621 629
37. B. Azab, S. Kedia, N. Shah, S. Vonfrolio, W. Lu, A. Naboush, and et al. The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer Int. J. Color. Dis. 28 2013 1629 1636
38. L.F. Onate-Ocana, V. Aiello-Crocifoglio, D. Gallardo-Rincon, R. Herrera-Goepfert, R. Brom-Valladares, J.F. Carrillo, and et al. Serum albumin as a significant prognostic factor for patients with gastric carcinoma Ann. Surg. Oncol. 14 2007 381 389
39. C.C. Lai, J.F. You, C.Y. Yeh, J.S. Chen, R. Tang, J.Y. Wang, and et al. Low preoperative serum albumin in colon cancer: a risk factor for poor outcome Int. J. Color. Dis. 26 2011 473 481